Maxim’s healthcare analyst Jason McCarthy weighed in today with an optimistic view on bluebird bio Inc (NASDAQ:BLUE), after spending an evening with bluebird management and clients, …
Maxim’s healthcare analyst Jason Kolbert weighed in today with an optimistic view on OncoSec Medical Inc (NASDAQ:ONCS), after the company announced positive results from a …
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a …
In a research report published today, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Galena Biopharma Inc (NASDAQ:GALE) with a $7 price …
Maxim analyst Jason McCarthy was out pounding the table on Kite Pharma Inc (NASDAQ:KITE) Thursday, reiterating a Buy rating and a price target of $87, which implies …
In a research report released today, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) and raised the price …
Maxim Group analyst Jason Kolbert weighed in today with his views on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), following the news that the company has commenced the promotion …
Health care analysts are weighing in today on the drug maker Keryx Biopharmaceuticals (NASDAQ:KERX), following the news that the Committee for Medicinal Products for Human Use in …
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on StemCells Inc (NASDAQ:STEM) with a $5.00 price target, after …
Bank of America Corp (NYSE:BAC) shares increased 2.74% to $17.
